Michael K Cao, MD
Cardiovascular Disease (Cardiology) · Rosemead
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 30 years
- Medical College of Wisconsin, 1996
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cao’s office at (626) 451-0086 to ask if they take your plan before you enroll.
California Medical Board record
Licence A80802 · Current
Licensed to practise in California · since 2002 · expires 2028-09-30 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$249,044
Medicare paid this office $249,044 for 991 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 948 | $148,561 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 301 | $47,384 | $157 |
| New patient visit (30+ min) | 171 | $13,560 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 195 | $11,287 | $57 |
| Ultrasound of both sides of head and neck blood flow | 37 | $5,297 | $143 |
See all 13 services
| Short return visit (20+ min) | 948 | $148,561 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 301 | $47,384 | $157 |
| New patient visit (30+ min) | 171 | $13,560 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 195 | $11,287 | $57 |
| Ultrasound of both sides of head and neck blood flow | 37 | $5,297 | $143 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $5,010 | $143 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 35 | $3,862 | $44 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 15 | $2,273 | $55 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 11 | $2,198 | $200 |
| Ultrasound of leg arteries or artery grafts | 11 | $1,984 | $180 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $1,726 | $52 |
| Ultrasound of leg arteries at rest and after exercise | 11 | $1,185 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 72 | $808 | $11 |
Who their Medicare patients are
991 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 58% · Also on Medicaid 90% · Health risk score 1.46. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 52% · Coronary heart disease 51% · Chronic kidney disease 46% · Heart failure 18% · COPD 18% · Atrial fibrillation 16% · Dementia 13% · Depression 12% · Stroke 9% · Cancer 8%.
The office billed $713,335, Medicare allowed $354,477 and paid $249,044; for 3,421 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 991 | 3,421 | 75 | 1.46 | $713,335 | $249,044 |
| 2023 | 960 | 3,760 | 75 | 1.51 | $821,080 | $300,002 |
| 2022 | 845 | 3,975 | 74 | 1.57 | $926,665 | $349,543 |
| 2021 | 1,383 | 6,308 | 75 | 2.03 | $1,216,945 | $459,407 |
| 2020 | 1,572 | 7,326 | 77 | 2.50 | $1,322,745 | $488,408 |
| 2019 | 1,754 | 8,784 | 76 | 2.43 | $1,731,515 | $597,637 |
| 2018 | 1,507 | 9,083 | 76 | 2.63 | $2,105,515 | $728,393 |
| 2017 | 1,196 | 9,050 | 77 | 2.56 | $2,391,090 | $880,710 |
| 2016 | 856 | 4,153 | 76 | 2.46 | $1,007,945 | $363,958 |
| 2015 | 1,465 | 8,607 | 77 | 3.17 | $1,693,795 | $664,269 |
| 2014 | 1,163 | 9,342 | 77 | 2.76 | $1,707,152 | $783,883 |
| 2013 | 889 | 3,530 | 73 | 2.41 | $599,420 | $224,013 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 866 | $161,629 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 311 | $50,000 | $161 |
| New patient visit (30+ min) | 202 | $16,643 | $82 |
| Ultrasound of both sides of head and neck blood flow | 72 | $10,912 | $152 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $10,880 | $165 |
| Ultrasound of leg arteries or artery grafts | 38 | $7,728 | $203 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 40 | $7,645 | $191 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 103 | $6,364 | $62 |
| Ultrasound of leg arteries at rest and after exercise | 34 | $3,878 | $114 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 30 | $3,369 | $46 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 18 | $2,980 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $2,946 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $2,192 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $557 | $10 |
2022: 17 services
| Short return visit (20+ min) | 747 | $163,062 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 328 | $59,054 | $178 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 168 | $28,960 | $172 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 102 | $21,748 | $213 |
| New patient visit (30+ min) | 167 | $15,135 | $91 |
| Ultrasound of both sides of head and neck blood flow | 80 | $13,969 | $175 |
| Ultrasound of leg arteries or artery grafts | 30 | $6,614 | $220 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $4,643 | $422 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 37 | $4,558 | $48 |
| Return visit (30+ min) | 30 | $3,683 | $105 |
| Ultrasound of leg arteries at rest and after exercise | 29 | $3,550 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 56 | $3,500 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 228 | $2,825 | $12 |
| Injection, regadenoson, 0.1 mg | 14 | $2,718 | None |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 19 | $2,463 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 38 | $2,281 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,084 | $54 |
2021: 21 services
| Short return visit (20+ min) | 700 | $184,210 | $71 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 384 | $70,103 | $183 |
| Injection, regadenoson, 0.1 mg | 161 | $30,466 | None |
| Ultrasound study of arm or leg veins with compression and maneuvers | 135 | $24,384 | $181 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 101 | $22,161 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $21,075 | $61 |
| Ultrasound of both sides of head and neck blood flow | 84 | $14,651 | $174 |
| New patient visit (30+ min) | 145 | $11,946 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 173 | $10,901 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $8,591 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 122 | $7,399 | $61 |
| Ultrasound of leg arteries or artery grafts | 27 | $6,285 | $233 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 23 | $5,930 | $258 |
| Return visit (30+ min) | 39 | $5,096 | $113 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $4,649 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 495 | $4,369 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 36 | $4,306 | $45 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 22 | $3,184 | $57 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 17 | $2,930 | $172 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 234 | $2,928 | $12 |
| Ultrasound of leg arteries at rest and after exercise | 24 | $2,587 | $108 |
2020: 23 services
| Short return visit (20+ min) | 670 | $150,289 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 333 | $61,467 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $53,747 | $62 |
| Injection, regadenoson, 0.1 mg | 213 | $40,139 | None |
| Ultrasound of both sides of head and neck blood flow | 147 | $26,780 | $182 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 154 | $25,636 | $165 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 92 | $19,459 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $14,192 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 207 | $13,569 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $12,004 | $63 |
| New patient visit (30+ min) | 111 | $9,421 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $8,248 | $118 |
| Return visit (30+ min) | 66 | $6,937 | $89 |
| Ultrasound of leg arteries or artery grafts | 25 | $6,043 | $232 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 83 | $5,987 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 618 | $5,353 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 42 | $3,974 | $40 |
| New patient visit (45+ min) | 24 | $3,238 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 194 | $2,977 | $14 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 15 | $2,478 | $165 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 20 | $2,451 | $51 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $1,668 | $19 |
| Blood test, clotting time | 11 | $588 | $4 |
2019: 27 services
| Short return visit (20+ min) | 717 | $166,784 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 454 | $83,197 | $180 |
| Injection, regadenoson, 0.1 mg | 271 | $49,828 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $41,134 | $62 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 71 | $30,623 | $431 |
| Ultrasound of both sides of head and neck blood flow | 130 | $23,011 | $176 |
| Ultrasound of leg arteries or artery grafts | 92 | $21,531 | $234 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 104 | $21,322 | $205 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 321 | $20,896 | $61 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 82 | $14,410 | $95 |
| Return visit (30+ min) | 114 | $12,416 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | $11,971 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 158 | $10,704 | $68 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 58 | $10,421 | $180 |
| New patient visit (30+ min) | 125 | $9,608 | $77 |
| Ultrasound of leg arteries at rest and after exercise | 74 | $9,304 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $8,343 | $116 |
| New patient visit (45+ min) | 56 | $7,359 | $131 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 805 | $7,188 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $6,964 | $88 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 27 | $6,661 | $247 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 292 | $4,428 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 44 | $4,054 | $35 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 25 | $2,611 | $48 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 15 | $2,517 | $168 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $1,515 | $20 |
| Blood test, clotting time | 11 | $548 | $4 |
2018: 30 services
| Return visit (30+ min) | 487 | $117,191 | $80 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 190 | $82,992 | $437 |
| Short return visit (20+ min) | 511 | $73,995 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 376 | $67,367 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 178 | $66,124 | $60 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 190 | $35,177 | $93 |
| Injection, regadenoson, 0.1 mg | 190 | $33,693 | None |
| Ultrasound of both sides of head and neck blood flow | 189 | $33,619 | $178 |
| Ultrasound of leg arteries or artery grafts | 124 | $29,063 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $19,017 | $87 |
| New patient visit (45+ min) | 159 | $18,978 | $119 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 89 | $17,874 | $201 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 266 | $17,806 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 231 | $16,655 | $71 |
| Ultrasound of leg arteries at rest and after exercise | 109 | $15,833 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $12,312 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 182 | $11,239 | $60 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 39 | $9,341 | $240 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 334 | $6,928 | $14 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 44 | $6,427 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 609 | $4,900 | $7 |
| New patient visit (30+ min) | 54 | $4,704 | $87 |
| Ultrasound of arm arteries or artery grafts | 23 | $4,046 | $176 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,849 | $167 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 39 | $2,871 | $29 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 15 | $1,578 | $39 |
| Programming of dual lead pacemaker system | 16 | $998 | $50 |
| Blood test, clotting time | 15 | $508 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $221 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $148 | $12 |
2017: 29 services
| Return visit (30+ min) | 470 | $172,979 | $87 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 219 | $97,289 | $444 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 375 | $75,348 | $199 |
| Ultrasound of both sides of head and neck blood flow | 348 | $63,366 | $180 |
| Ultrasound of leg arteries or artery grafts | 243 | $58,049 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $56,442 | $61 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 219 | $40,380 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $40,222 | $88 |
| Ultrasound of leg arteries at rest and after exercise | 248 | $38,644 | $155 |
| Injection, regadenoson, 0.1 mg | 219 | $36,960 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 114 | $27,650 | $243 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 123 | $21,329 | $172 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 272 | $20,648 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 288 | $18,315 | $60 |
| New patient visit (45+ min) | 158 | $18,300 | $116 |
| Critical care, first 30-74 minutes | 24 | $17,798 | $185 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $9,780 | $115 |
| Long return visit (40+ min) | 57 | $9,750 | $116 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 157 | $9,134 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,655 | $173 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 344 | $6,777 | $14 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 34 | $6,273 | $179 |
| Ultrasound of arm arteries or artery grafts | 21 | $3,877 | $185 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 429 | $3,665 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 38 | $2,662 | $31 |
| Short return visit (20+ min) | 29 | $2,129 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $1,307 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $847 | $16 |
| Blood test, clotting time | 12 | $618 | $5 |
2016: 22 services
| Return visit (30+ min) | 331 | $83,493 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $74,632 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 314 | $62,444 | $192 |
| Critical care, first 30-74 minutes | 47 | $45,067 | $185 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 75 | $17,603 | $229 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 196 | $13,414 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,774 | $166 |
| Long return visit (40+ min) | 52 | $11,131 | $120 |
| New patient visit (45+ min) | 66 | $8,307 | $126 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $5,266 | $53 |
| Short return visit (20+ min) | 74 | $4,436 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $3,150 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 276 | $2,287 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 34 | $2,004 | $29 |
| New patient visit (30+ min) | 26 | $1,890 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 118 | $1,712 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,364 | $114 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $1,346 | $16 |
| Blood test, clotting time | 21 | $919 | $5 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $880 | $52 |
| Programming of dual lead pacemaker system | 13 | $829 | $49 |
| Insertion of needle into vein for collection of blood sample | 24 | $85 | $3 |
2015: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 349 | $171,870 | $61 |
| Critical care, first 30-74 minutes | 151 | $165,741 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $68,492 | $87 |
| Short return visit (20+ min) | 339 | $55,282 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 263 | $52,682 | $196 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 304 | $45,250 | $115 |
| Return visit (30+ min) | 177 | $26,515 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $17,094 | $53 |
| New patient visit (30+ min) | 150 | $12,419 | $83 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 102 | $7,449 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,863 | $167 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 594 | $5,222 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,469 | $64 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $3,215 | $179 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 39 | $2,407 | $33 |
| New patient visit (45+ min) | 16 | $2,240 | $140 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 134 | $1,991 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 97 | $1,850 | $19 |
| Programming of dual lead pacemaker system | 26 | $1,837 | $47 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $1,161 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 92 | $1,143 | $12 |
| Blood test, clotting time | 24 | $582 | $5 |
| Insertion of needle into vein for collection of blood sample | 39 | $162 | $3 |
2014: 24 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 301 | $195,658 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 342 | $157,229 | $60 |
| Critical care, first 30-74 minutes | 136 | $144,389 | $186 |
| Short return visit (20+ min) | 342 | $69,659 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $47,664 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 179 | $37,117 | $169 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 217 | $27,838 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 338 | $20,092 | $54 |
| New patient visit (30+ min) | 232 | $18,845 | $81 |
| Insertion of implantable defibrillator system | 12 | $9,307 | $776 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 104 | $7,357 | $69 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,572 | $438 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 68 | $4,091 | $59 |
| Return visit (30+ min) | 28 | $3,154 | $81 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $3,002 | $214 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 194 | $2,499 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 208 | $1,794 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,487 | $55 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,179 | $66 |
| Programming of dual lead pacemaker system | 16 | $1,054 | $48 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 30 | $970 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 59 | $717 | $12 |
| Blood test, clotting time | 23 | $652 | $5 |
| Insertion of needle into vein for collection of blood sample | 66 | $288 | $3 |
2013: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 175 | $58,472 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $26,169 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $21,707 | $83 |
| Short return visit (20+ min) | 153 | $19,551 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 126 | $14,995 | $110 |
| New patient visit (45+ min) | 79 | $10,659 | $135 |
| Insertion of implantable defibrillator system | 13 | $8,763 | $674 |
| Return visit (30+ min) | 63 | $8,571 | $89 |
| New patient visit (30+ min) | 82 | $7,064 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $4,984 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 36 | $2,981 | $75 |
| Short return visit (20+ min) | 78 | $2,892 | $30 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 239 | $2,592 | $11 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,283 | $163 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 143 | $2,205 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,623 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $1,351 | $18 |
| Short return visit | 70 | $1,211 | $15 |
| Programming of dual lead pacemaker system | 43 | $1,202 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 121 | $969 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $965 | $54 |
| Programming of dual lead pacemaker system | 13 | $797 | $47 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 30 | $527 | $18 |
| Programming of dual lead implantable defibrillator system | 12 | $516 | $34 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $300 | $19 |
| Blood test, clotting time | 13 | $296 | $5 |
| Insertion of needle into vein for collection of blood sample | 39 | $171 | $3 |
Medicaid work
$92,282 in 2024
Medicaid paid $92,282 for 4,506 billed services this clinician did in 2024, up to 198 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 427 | $29,695 |
| Return visit (30+ min) | 852 | $19,230 |
| CARDIOVASCULAR STRESS TEST | 518 | $12,930 |
| Short return visit (20+ min) | 1,474 | $10,303 |
| New patient visit (45+ min) | 224 | $5,627 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 625 | $5,276 |
| New patient visit (30+ min) | 246 | $4,294 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 51 | $1,825 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 31 | $1,752 |
| Injection, regadenoson, 0.1 mg | 29 | $766 |
| Tc99m sestamibi | 29 | $584 |
| 2024 | 4,506 | 11 | 198 | $92,282 |
| 2023 | 5,810 | 12 | 239 | $191,555 |
| 2022 | 5,109 | 14 | 217 | $178,597 |
| 2021 | 5,458 | 13 | 173 | $187,418 |
| 2020 | 5,306 | 11 | 167 | $194,849 |
| 2019 | 5,973 | 12 | 168 | $210,221 |
| 2018 | 6,843 | 16 | 180 | $190,673 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 556 | $61,202 |
| CARDIOVASCULAR STRESS TEST | 629 | $27,187 |
| Return visit (30+ min) | 867 | $23,729 |
| Short return visit (20+ min) | 2,168 | $22,715 |
| New patient visit (30+ min) | 435 | $11,887 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 44 | $10,402 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 759 | $9,682 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 56 | $7,459 |
| New patient visit (45+ min) | 146 | $5,673 |
| Injection, regadenoson, 0.1 mg | 43 | $5,054 |
| Tc99m sestamibi | 44 | $3,696 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 63 | $2,871 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 528 | $61,717 |
| Short return visit (20+ min) | 2,120 | $31,557 |
| Return visit (30+ min) | 828 | $21,400 |
| CARDIOVASCULAR STRESS TEST | 395 | $19,158 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 79 | $11,124 |
| New patient visit (30+ min) | 302 | $9,861 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 621 | $6,540 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 29 | $6,136 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 55 | $3,806 |
| EXTREMITY STUDY | 42 | $2,058 |
| Tc99m sestamibi | 28 | $1,882 |
| Injection, regadenoson, 0.1 mg | 29 | $1,363 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 581 | $59,740 |
| Short return visit (20+ min) | 1,774 | $33,776 |
| Return visit (30+ min) | 1,126 | $24,890 |
| CARDIOVASCULAR STRESS TEST | 408 | $19,715 |
| New patient visit (30+ min) | 296 | $10,965 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 97 | $10,058 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 26 | $6,695 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 575 | $5,762 |
| Injection, regadenoson, 0.1 mg | 53 | $5,604 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 97 | $4,829 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 387 | $3,177 |
| Tc99m sestamibi | 26 | $2,040 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 686 | $74,995 |
| Short return visit (20+ min) | 1,557 | $27,151 |
| Return visit (30+ min) | 1,070 | $22,076 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 157 | $17,290 |
| CARDIOVASCULAR STRESS TEST | 362 | $16,435 |
| New patient visit (30+ min) | 278 | $11,497 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 176 | $10,299 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 569 | $5,924 |
| Injection, regadenoson, 0.1 mg | 63 | $5,685 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 374 | $3,151 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 14 | $346 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 752 | $77,117 |
| Return visit (30+ min) | 1,256 | $27,524 |
| Short return visit (20+ min) | 1,553 | $21,846 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 171 | $20,763 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 281 | $15,750 |
| CARDIOVASCULAR STRESS TEST | 384 | $15,672 |
| New patient visit (30+ min) | 348 | $12,128 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 619 | $6,745 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 26 | $5,592 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 532 | $3,914 |
| Injection, regadenoson, 0.1 mg | 25 | $2,148 |
| Tc99m sestamibi | 26 | $1,023 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 735 | $53,609 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 112 | $22,576 |
| Return visit (30+ min) | 1,841 | $20,939 |
| CARDIOVASCULAR STRESS TEST | 561 | $17,649 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 406 | $15,973 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 115 | $13,347 |
| Short return visit (20+ min) | 1,164 | $12,169 |
| Injection, regadenoson, 0.1 mg | 115 | $8,531 |
| New patient visit (30+ min) | 234 | $7,569 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 648 | $6,717 |
| Tc99m sestamibi | 112 | $6,565 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 461 | $2,946 |
Drugs they prescribed that Part D paid
$782,872
Pharmacies billed $782,872 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,820) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,726 generic and fewer than 11 brand-name prescriptions · $782,872 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 423 | $318,079 | $752 |
| Entresto | 176 | $147,504 | $838 |
| Eliquis | 165 | $130,573 | $791 |
| Brilinta | 80 | $40,088 | $501 |
| Multaq | 39 | $39,451 | $1,012 |
See all 52 drugs
| Xarelto | 423 | $318,079 | $752 |
| Entresto | 176 | $147,504 | $838 |
| Eliquis | 165 | $130,573 | $791 |
| Brilinta | 80 | $40,088 | $501 |
| Multaq | 39 | $39,451 | $1,012 |
| Vascepa | 126 | $26,783 | $213 |
| Amiodarone | 200 | $9,984 | $50 |
| Ranolazine Er | 190 | $8,335 | $44 |
| Icosapent Ethyl | 45 | $6,946 | $154 |
| Isosorbide Dinitrate | 159 | $5,383 | $34 |
| Metoprolol | 407 | $4,786 | $12 |
| Atorvastatin | 723 | $4,558 | $6 |
| Hydralazine | 366 | $3,072 | $8 |
| Nifedipine Er | 171 | $2,844 | $17 |
| Pradaxa | 12 | $2,800 | $233 |
| Losartan | 389 | $2,396 | $6 |
| Carvedilol | 313 | $1,696 | $5 |
| Clopidogrel | 254 | $1,650 | $6 |
| Atenolol | 259 | $1,539 | $6 |
| Labetalol | 47 | $1,444 | $31 |
| Amlodipine Besylate | 467 | $1,277 | $3 |
| Nitroglycerin | 176 | $1,206 | $7 |
| Omega-3 Acid Ethyl Esters | 30 | $1,061 | $35 |
| Isosorbide Mononitrate Er | 106 | $894 | $8 |
| Diltiazem 24hr Er (Cd) | 41 | $861 | $21 |
| Metoprolol | 235 | $848 | $4 |
| Cilostazol | 53 | $821 | $15 |
| Fenofibrate | 51 | $804 | $16 |
| Propafenone | 33 | $689 | $21 |
| Diltiazem | 25 | $610 | $24 |
| Propranolol | 55 | $598 | $11 |
| Digoxin | 64 | $582 | $9 |
| Midodrine | 13 | $536 | $41 |
| Benazepril | 41 | $514 | $13 |
| Potassium Chloride | 44 | $492 | $11 |
| Furosemide | 126 | $381 | $3 |
| Spironolactone | 84 | $341 | $4 |
| Rosuvastatin | 34 | $332 | $10 |
| Ezetimibe | 26 | $330 | $13 |
| Warfarin | 118 | $326 | $3 |
| Lisinopril | 52 | $311 | $6 |
| Sotalol | 11 | $297 | $27 |
| Bisoprolol | 24 | $287 | $12 |
| Clonidine | 73 | $276 | $4 |
| Theophylline Er | 11 | $236 | $21 |
| Fenofibrate | 12 | $158 | $13 |
| Olmesartan Medoxomil | 16 | $147 | $9 |
| Flecainide Acetate | 12 | $136 | $11 |
| Simvastatin | 39 | $135 | $3 |
| Fenofibrate | 15 | $118 | $8 |
| Hydrochlorothiazide | 86 | $81 | $1 |
| Pravastatin | 25 | $74 | $3 |
Year by year
| 2024 | 6,820 | 755 | 0% (0) | None | $782,872 |
| 2023 | 7,038 | 846 | 0% (0) | 16% | $1,010,410 |
| 2022 | 7,688 | 835 | 0% (0) | 16% | $949,991 |
| 2021 | 9,352 | 900 | 0% (0) | 15% | $879,776 |
| 2020 | 11,078 | 857 | 0% (0) | 15% | $848,296 |
| 2019 | 11,468 | 885 | None | None | $910,005 |
| 2018 | 10,354 | 819 | None | None | $780,943 |
| 2017 | 8,040 | 606 | None | 18% | $431,946 |
| 2016 | 5,337 | 428 | None | None | $230,932 |
| 2015 | 5,416 | 417 | None | None | $229,240 |
| 2014 | 5,123 | 371 | 0% (20) | 27% | $198,418 |
| 2013 | 2,098 | 210 | 1% (20) | None | $73,652 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 52 drugs
| Xarelto | 375 | $335,376 | $894 |
| Entresto | 139 | $161,831 | $1,164 |
| Eliquis | 139 | $148,427 | $1,068 |
| Brilinta | 160 | $99,015 | $619 |
| Vascepa | 149 | $45,389 | $305 |
| Multaq | 21 | $41,418 | $1,972 |
| Ranolazine Er | 190 | $18,441 | $97 |
| Atorvastatin | 782 | $15,446 | $20 |
| Metoprolol | 426 | $9,371 | $22 |
| Isosorbide Dinitrate | 146 | $8,447 | $58 |
| Amlodipine Besylate | 506 | $8,056 | $16 |
| Losartan | 398 | $7,949 | $20 |
| Nifedipine Er | 157 | $7,469 | $48 |
| Hydralazine | 318 | $7,445 | $23 |
| Amiodarone | 127 | $7,390 | $58 |
| Icosapent Ethyl | 26 | $6,990 | $269 |
| Carvedilol | 320 | $6,735 | $21 |
| Atenolol | 305 | $5,281 | $17 |
| Pradaxa | 13 | $4,991 | $384 |
| Clopidogrel | 239 | $4,420 | $18 |
| Nitroglycerin | 244 | $3,556 | $15 |
| Metoprolol | 265 | $3,342 | $13 |
| Labetalol | 36 | $3,147 | $87 |
| Fenofibrate | 52 | $2,763 | $53 |
| Isosorbide Mononitrate Er | 122 | $2,673 | $22 |
| Omega-3 Acid Ethyl Esters | 33 | $1,713 | $52 |
| Diltiazem | 31 | $1,399 | $45 |
| Ezetimibe | 41 | $1,370 | $33 |
| Diltiazem 24hr Er (Cd) | 54 | $1,338 | $25 |
| Clonidine | 101 | $1,238 | $12 |
| Cilostazol | 50 | $1,133 | $23 |
| Propranolol | 40 | $1,098 | $27 |
| Warfarin | 153 | $1,079 | $7 |
| Rosuvastatin | 52 | $1,063 | $20 |
| Simvastatin | 52 | $984 | $19 |
| Potassium Chloride | 46 | $966 | $21 |
| Lisinopril | 59 | $912 | $15 |
| Olmesartan Medoxomil | 26 | $908 | $35 |
| Benazepril | 43 | $884 | $21 |
| Pacerone | 13 | $833 | $64 |
| Sotalol | 16 | $826 | $52 |
| Furosemide | 129 | $802 | $6 |
| Valsartan | 24 | $793 | $33 |
| Digoxin | 40 | $757 | $19 |
| Spironolactone | 77 | $735 | $10 |
| Bisoprolol | 13 | $675 | $52 |
| Propafenone | 32 | $659 | $21 |
| Fenofibrate | 19 | $491 | $26 |
| Hydrochlorothiazide | 69 | $322 | $5 |
| Enalapril Maleate | 21 | $304 | $14 |
| Pravastatin | 25 | $281 | $11 |
| Bumetanide | 15 | $179 | $12 |
2022: 55 drugs
| Xarelto | 324 | $285,539 | $881 |
| Entresto | 154 | $162,877 | $1,058 |
| Eliquis | 165 | $128,320 | $778 |
| Brilinta | 169 | $105,380 | $624 |
| Vascepa | 191 | $56,408 | $295 |
| Multaq | 27 | $39,186 | $1,451 |
| Ranolazine Er | 224 | $32,943 | $147 |
| Repatha Sureclick | 15 | $9,328 | $622 |
| Nifedipine Er | 177 | $8,784 | $50 |
| Atorvastatin | 825 | $8,672 | $11 |
| Amiodarone | 107 | $7,986 | $75 |
| Pradaxa | 14 | $7,408 | $529 |
| Metoprolol | 444 | $6,692 | $15 |
| Midodrine | 13 | $6,328 | $487 |
| Hydralazine | 369 | $5,896 | $16 |
| Losartan | 465 | $5,746 | $12 |
| Isosorbide Dinitrate | 91 | $5,468 | $60 |
| Fenofibrate | 75 | $4,725 | $63 |
| Ezetimibe | 36 | $4,469 | $124 |
| Amlodipine Besylate | 573 | $4,056 | $7 |
| Carvedilol | 360 | $3,884 | $11 |
| Nitroglycerin | 222 | $3,571 | $16 |
| Pacerone | 42 | $3,149 | $75 |
| Clopidogrel | 293 | $2,987 | $10 |
| Labetalol | 32 | $2,847 | $89 |
| Atenolol | 330 | $2,820 | $9 |
| Rosuvastatin | 45 | $2,562 | $57 |
| Olmesartan Medoxomil | 38 | $1,955 | $51 |
| Isosorbide Mononitrate Er | 170 | $1,936 | $11 |
| Diltiazem 24hr Er (Cd) | 47 | $1,898 | $40 |
| Icosapent Ethyl | 14 | $1,877 | $134 |
| Metoprolol | 222 | $1,695 | $8 |
| Potassium Chloride | 87 | $1,272 | $15 |
| Propafenone | 41 | $1,265 | $31 |
| Digoxin | 34 | $1,104 | $32 |
| Omega-3 Acid Ethyl Esters | 29 | $1,024 | $35 |
| Valsartan | 21 | $983 | $47 |
| Fenofibrate | 28 | $947 | $34 |
| Propranolol | 62 | $866 | $14 |
| Lisinopril | 81 | $802 | $10 |
| Warfarin | 176 | $779 | $4 |
| Furosemide | 182 | $748 | $4 |
| Cilostazol | 55 | $741 | $13 |
| Sotalol | 33 | $710 | $22 |
| Simvastatin | 82 | $605 | $7 |
| Diltiazem | 32 | $583 | $18 |
| Losartan-Hydrochlorothiazide | 21 | $530 | $25 |
| Clonidine | 98 | $526 | $5 |
| Spironolactone | 78 | $501 | $6 |
| Benazepril | 29 | $356 | $12 |
| Hydrochlorothiazide | 65 | $324 | $5 |
| Irbesartan | 11 | $276 | $25 |
| Pravastatin | 24 | $207 | $9 |
| Amoxicillin | 23 | $86 | $4 |
| Enalapril Maleate | 12 | $55 | $5 |
2021: 54 drugs
| Xarelto | 386 | $265,774 | $689 |
| Entresto | 226 | $182,703 | $808 |
| Eliquis | 165 | $106,739 | $647 |
| Brilinta | 180 | $95,881 | $533 |
| Multaq | 48 | $46,093 | $960 |
| Vascepa | 192 | $43,321 | $226 |
| Ranolazine Er | 324 | $28,055 | $87 |
| Atorvastatin | 1,026 | $9,900 | $10 |
| Nifedipine Er | 256 | $8,741 | $34 |
| Isosorbide Dinitrate | 155 | $8,208 | $53 |
| Metoprolol | 571 | $7,501 | $13 |
| Hydralazine | 570 | $6,184 | $11 |
| Pradaxa | 12 | $6,122 | $510 |
| Losartan | 570 | $4,794 | $8 |
| Labetalol | 57 | $4,504 | $79 |
| Amlodipine Besylate | 704 | $3,888 | $6 |
| Nitroglycerin | 225 | $3,539 | $16 |
| Fenofibrate | 91 | $3,421 | $38 |
| Carvedilol | 451 | $3,100 | $7 |
| Diltiazem 24hr Er (Cd) | 58 | $2,548 | $44 |
| Clopidogrel | 333 | $2,482 | $7 |
| Atenolol | 337 | $2,398 | $7 |
| Rosuvastatin | 68 | $2,179 | $32 |
| Ezetimibe | 49 | $1,874 | $38 |
| Amiodarone | 72 | $1,829 | $25 |
| Olmesartan Medoxomil | 39 | $1,676 | $43 |
| Isosorbide Mononitrate Er | 166 | $1,420 | $9 |
| Midodrine | 16 | $1,402 | $88 |
| Propafenone | 49 | $1,289 | $26 |
| Metoprolol | 292 | $1,251 | $4 |
| Potassium Chloride | 138 | $1,250 | $9 |
| Prasugrel | 21 | $1,108 | $53 |
| Propranolol | 75 | $1,009 | $13 |
| Pacerone | 13 | $816 | $63 |
| Fenofibrate | 14 | $769 | $55 |
| Digoxin | 28 | $757 | $27 |
| Warfarin | 157 | $706 | $4 |
| Cilostazol | 81 | $693 | $9 |
| Furosemide | 238 | $668 | $3 |
| Valsartan | 25 | $667 | $27 |
| Clonidine | 139 | $666 | $5 |
| Losartan-Hydrochlorothiazide | 19 | $638 | $34 |
| Spironolactone | 114 | $617 | $5 |
| Diltiazem | 29 | $586 | $20 |
| Lisinopril | 105 | $502 | $5 |
| Sotalol | 30 | $465 | $15 |
| Simvastatin | 115 | $396 | $3 |
| Benazepril | 32 | $331 | $10 |
| Hydrochlorothiazide | 64 | $187 | $3 |
| Pravastatin | 24 | $127 | $5 |
| Digitek | 13 | $104 | $8 |
| Amoxicillin | 26 | $87 | $3 |
| Enalapril Maleate | 16 | $81 | $5 |
| Klor-Con M20 | 12 | $76 | $6 |
2020: 60 drugs
| Xarelto | 484 | $283,842 | $586 |
| Entresto | 240 | $147,211 | $613 |
| Multaq | 110 | $83,631 | $760 |
| Brilinta | 176 | $78,406 | $445 |
| Eliquis | 143 | $77,655 | $543 |
| Ranolazine Er | 378 | $28,369 | $75 |
| Vascepa | 158 | $28,288 | $179 |
| Atorvastatin | 1,196 | $8,532 | $7 |
| Metoprolol | 639 | $7,900 | $12 |
| Hydralazine | 608 | $7,716 | $13 |
| Nifedipine Er | 311 | $6,597 | $21 |
| Isosorbide Dinitrate | 156 | $6,450 | $41 |
| Amiodarone | 136 | $6,119 | $45 |
| Pradaxa | 12 | $5,787 | $482 |
| Losartan | 700 | $4,607 | $7 |
| Nitroglycerin | 254 | $4,211 | $17 |
| Bystolic | 23 | $3,932 | $171 |
| Fenofibrate | 113 | $3,724 | $33 |
| Midodrine | 32 | $3,189 | $100 |
| Rosuvastatin | 67 | $3,163 | $47 |
| Carvedilol | 619 | $3,152 | $5 |
| Labetalol | 57 | $3,123 | $55 |
| Amlodipine Besylate | 911 | $3,117 | $3 |
| Ezetimibe | 68 | $2,073 | $30 |
| Clopidogrel | 347 | $2,058 | $6 |
| Losartan-Hydrochlorothiazide | 21 | $1,944 | $93 |
| Potassium Chloride | 213 | $1,797 | $8 |
| Isosorbide Mononitrate Er | 220 | $1,757 | $8 |
| Diltiazem 24hr Er (Cd) | 51 | $1,522 | $30 |
| Atenolol | 333 | $1,327 | $4 |
| Metoprolol | 371 | $1,276 | $3 |
| Olmesartan Medoxomil | 35 | $1,196 | $34 |
| Clonidine | 212 | $1,187 | $6 |
| Digoxin | 30 | $1,085 | $36 |
| Cilostazol | 119 | $1,019 | $9 |
| Digitek | 28 | $910 | $32 |
| Warfarin | 152 | $855 | $6 |
| Flecainide Acetate | 22 | $849 | $39 |
| Propafenone | 51 | $842 | $17 |
| Propranolol | 51 | $809 | $16 |
| Valsartan | 14 | $790 | $56 |
| Furosemide | 284 | $759 | $3 |
| Fenofibrate | 12 | $743 | $62 |
| Clonidine | 11 | $699 | $64 |
| Lisinopril | 145 | $524 | $4 |
| Sotalol | 25 | $506 | $20 |
| Diltiazem | 34 | $460 | $14 |
| Simvastatin | 160 | $448 | $3 |
| Spironolactone | 117 | $428 | $4 |
| Fenofibrate | 15 | $416 | $28 |
| Benazepril | 60 | $406 | $7 |
| Levothyroxine | 12 | $291 | $24 |
| Hydrochlorothiazide | 78 | $262 | $3 |
| Irbesartan | 12 | $194 | $16 |
| Enalapril Maleate | 20 | $192 | $10 |
| Omeprazole | 12 | $166 | $14 |
| Pravastatin | 23 | $123 | $5 |
| Amoxicillin | 25 | $119 | $5 |
| Pantoprazole | 13 | $85 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $66 | $5 |
2019: 63 drugs
| Xarelto | 494 | $263,171 | $533 |
| Entresto | 313 | $166,865 | $533 |
| Multaq | 135 | $91,317 | $676 |
| Ranexa | 284 | $86,642 | $305 |
| Eliquis | 137 | $70,028 | $511 |
| Brilinta | 145 | $59,131 | $408 |
| Ranolazine Er | 243 | $27,781 | $114 |
| Vascepa | 92 | $12,628 | $137 |
| Atorvastatin | 1,276 | $10,499 | $8 |
| Metoprolol | 666 | $9,791 | $15 |
| Hydralazine | 585 | $7,786 | $13 |
| Isosorbide Dinitrate | 169 | $6,713 | $40 |
| Nifedipine Er | 285 | $5,660 | $20 |
| Nitroglycerin | 313 | $5,264 | $17 |
| Amiodarone | 120 | $4,585 | $38 |
| Carvedilol | 616 | $4,183 | $7 |
| Ezetimibe | 101 | $3,949 | $39 |
| Rosuvastatin | 66 | $3,760 | $57 |
| Fenofibrate | 199 | $3,733 | $19 |
| Losartan | 599 | $3,156 | $5 |
| Amlodipine Besylate | 842 | $3,068 | $4 |
| Labetalol | 54 | $2,773 | $51 |
| Bystolic | 19 | $2,754 | $145 |
| Midodrine | 36 | $2,671 | $74 |
| Clopidogrel | 422 | $2,361 | $6 |
| Cilostazol | 257 | $2,297 | $9 |
| Isosorbide Mononitrate Er | 239 | $2,093 | $9 |
| Metoprolol | 412 | $1,708 | $4 |
| Enoxaparin | 12 | $1,342 | $112 |
| Digox | 44 | $1,301 | $30 |
| Potassium Chloride | 132 | $1,150 | $9 |
| Clonidine | 220 | $1,063 | $5 |
| Atenolol | 273 | $1,033 | $4 |
| Propafenone | 46 | $1,003 | $22 |
| Propranolol | 55 | $955 | $17 |
| Flecainide Acetate | 23 | $931 | $40 |
| Warfarin | 148 | $891 | $6 |
| Esomeprazole Magnesium | 15 | $716 | $48 |
| Lisinopril | 154 | $643 | $4 |
| Furosemide | 226 | $631 | $3 |
| Sotalol | 24 | $573 | $24 |
| Simvastatin | 167 | $571 | $3 |
| Digoxin | 21 | $552 | $26 |
| Prasugrel | 13 | $505 | $39 |
| Digitek | 23 | $485 | $21 |
| Fenofibrate | 20 | $458 | $23 |
| Diltiazem | 42 | $432 | $10 |
| Levothyroxine | 19 | $412 | $22 |
| Diltiazem 24hr Er (Cd) | 23 | $361 | $16 |
| Fenofibrate | 15 | $347 | $23 |
| Spironolactone | 93 | $342 | $4 |
| Benazepril | 66 | $329 | $5 |
| Enalapril Maleate | 22 | $328 | $15 |
| Metolazone | 14 | $310 | $22 |
| Losartan-Hydrochlorothiazide | 47 | $275 | $6 |
| Pravastatin | 25 | $262 | $10 |
| Pantoprazole | 21 | $235 | $11 |
| Omeprazole | 16 | $191 | $12 |
| Amoxicillin | 28 | $139 | $5 |
| Hydrochlorothiazide | 51 | $128 | $3 |
| Ranitidine | 17 | $128 | $8 |
| Glimepiride | 11 | $122 | $11 |
| Triamterene-Hydrochlorothiazid | 14 | $50 | $4 |
2018: 66 drugs
| Xarelto | 397 | $200,094 | $504 |
| Entresto | 271 | $133,278 | $492 |
| Ranexa | 456 | $120,801 | $265 |
| Multaq | 125 | $80,279 | $642 |
| Eliquis | 152 | $69,981 | $460 |
| Brilinta | 101 | $41,851 | $414 |
| Atorvastatin | 1,193 | $10,576 | $9 |
| Isosorbide Dinitrate | 159 | $7,797 | $49 |
| Metoprolol | 505 | $6,684 | $13 |
| Hydralazine | 591 | $6,597 | $11 |
| Amiodarone | 139 | $6,475 | $47 |
| Lyrica | 16 | $4,692 | $293 |
| Fenofibrate | 226 | $4,547 | $20 |
| Ezetimibe | 45 | $4,519 | $100 |
| Nifedipine Er | 253 | $4,481 | $18 |
| Nitroglycerin | 212 | $3,993 | $19 |
| Esomeprazole Magnesium | 20 | $3,150 | $157 |
| Isosorbide Mononitrate Er | 279 | $2,946 | $11 |
| Carvedilol | 504 | $2,915 | $6 |
| Clopidogrel | 420 | $2,501 | $6 |
| Losartan | 523 | $2,485 | $5 |
| Rosuvastatin | 51 | $2,431 | $48 |
| Cilostazol | 289 | $2,417 | $8 |
| Amlodipine Besylate | 692 | $2,180 | $3 |
| Omega-3 Acid Ethyl Esters | 39 | $2,119 | $54 |
| Enoxaparin | 12 | $1,828 | $152 |
| Labetalol | 40 | $1,744 | $44 |
| Digoxin | 61 | $1,733 | $28 |
| Midodrine | 18 | $1,718 | $95 |
| Niacin Er | 17 | $1,612 | $95 |
| Metoprolol | 408 | $1,540 | $4 |
| Digox | 44 | $1,376 | $31 |
| Propafenone | 57 | $1,147 | $20 |
| Warfarin | 137 | $1,069 | $8 |
| Potassium Chloride | 110 | $1,067 | $10 |
| Clonidine | 202 | $1,014 | $5 |
| Furosemide | 208 | $1,010 | $5 |
| Atenolol | 187 | $955 | $5 |
| Flecainide Acetate | 18 | $862 | $48 |
| Valsartan | 38 | $810 | $21 |
| Simvastatin | 158 | $736 | $5 |
| Diltiazem | 39 | $534 | $14 |
| Propranolol | 47 | $487 | $10 |
| Diltiazem 24hr Er (Cd) | 19 | $467 | $25 |
| Benazepril | 87 | $443 | $5 |
| Lisinopril | 101 | $434 | $4 |
| Pravastatin | 29 | $415 | $14 |
| Afeditab Cr | 22 | $400 | $18 |
| Spironolactone | 86 | $373 | $4 |
| Gabapentin | 18 | $297 | $17 |
| Levothyroxine | 14 | $294 | $21 |
| Theophylline | 11 | $291 | $26 |
| Fenofibrate | 15 | $282 | $19 |
| Gemfibrozil | 19 | $204 | $11 |
| Ramipril | 12 | $176 | $15 |
| Omeprazole | 28 | $146 | $5 |
| Losartan-Hydrochlorothiazide | 24 | $134 | $6 |
| Levofloxacin | 27 | $133 | $5 |
| Pentoxifylline | 14 | $120 | $9 |
| Hydrochlorothiazide | 35 | $119 | $3 |
| Sotalol | 18 | $115 | $6 |
| Pantoprazole | 17 | $112 | $7 |
| Amoxicillin | 30 | $86 | $3 |
| Triamterene-Hydrochlorothiazid | 13 | $71 | $5 |
| Ranitidine | 13 | $48 | $4 |
| Famotidine | 12 | $22 | $2 |
2017: 59 drugs
| Xarelto | 403 | $168,804 | $419 |
| Entresto | 111 | $47,378 | $427 |
| Ranexa | 157 | $35,004 | $223 |
| Multaq | 44 | $30,041 | $683 |
| Eliquis | 36 | $15,670 | $435 |
| Brilinta | 33 | $14,888 | $451 |
| Pradaxa | 26 | $9,794 | $377 |
| Crestor | 26 | $8,347 | $321 |
| Atorvastatin | 947 | $8,233 | $9 |
| Hydralazine | 445 | $5,983 | $13 |
| Metoprolol | 385 | $5,276 | $14 |
| Fenofibrate | 201 | $4,610 | $23 |
| Amiodarone | 152 | $4,561 | $30 |
| Isosorbide Dinitrate | 82 | $4,014 | $49 |
| Omega-3 Acid Ethyl Esters | 45 | $4,006 | $89 |
| Isosorbide Mononitrate Er | 322 | $3,763 | $12 |
| Nifedipine Er | 159 | $3,401 | $21 |
| Nexium | 12 | $3,074 | $256 |
| Clopidogrel | 466 | $3,005 | $6 |
| Nitroglycerin | 117 | $2,544 | $22 |
| Carvedilol | 413 | $2,268 | $5 |
| Digoxin | 53 | $2,262 | $43 |
| Potassium Chloride | 130 | $2,159 | $17 |
| Losartan | 346 | $1,888 | $5 |
| Rosuvastatin | 26 | $1,792 | $69 |
| Cilostazol | 185 | $1,650 | $9 |
| Amlodipine Besylate | 554 | $1,628 | $3 |
| Afeditab Cr | 68 | $1,284 | $19 |
| Metolazone | 31 | $1,270 | $41 |
| Furosemide | 283 | $1,262 | $4 |
| Labetalol | 25 | $1,188 | $48 |
| Valsartan | 46 | $1,122 | $24 |
| Digox | 30 | $1,075 | $36 |
| Warfarin | 131 | $1,051 | $8 |
| Metoprolol | 249 | $1,028 | $4 |
| Niacin Er | 11 | $983 | $89 |
| Simvastatin | 164 | $801 | $5 |
| Propafenone | 48 | $682 | $14 |
| Atenolol | 177 | $676 | $4 |
| Clonidine | 139 | $625 | $4 |
| Spironolactone | 114 | $606 | $5 |
| Diltiazem | 34 | $594 | $17 |
| Lisinopril | 98 | $574 | $6 |
| Nitrostat | 16 | $480 | $30 |
| Diltiazem 24hr Er | 35 | $468 | $13 |
| Enalapril Maleate | 17 | $467 | $27 |
| Fenofibrate | 17 | $333 | $20 |
| Ramipril | 11 | $281 | $26 |
| Benazepril | 48 | $218 | $5 |
| Pravastatin | 14 | $198 | $14 |
| Baclofen | 11 | $163 | $15 |
| Minoxidil | 12 | $98 | $8 |
| Levofloxacin | 15 | $93 | $6 |
| Triamterene-Hydrochlorothiazid | 13 | $86 | $7 |
| Losartan-Hydrochlorothiazide | 15 | $73 | $5 |
| Ranitidine | 17 | $70 | $4 |
| Pantoprazole | 12 | $69 | $6 |
| Amoxicillin | 24 | $54 | $2 |
| Hydrochlorothiazide | 24 | $51 | $2 |
2016: 49 drugs
| Xarelto | 223 | $87,520 | $392 |
| Eliquis | 39 | $17,431 | $447 |
| Ranexa | 41 | $13,201 | $322 |
| Pradaxa | 35 | $12,878 | $368 |
| Crestor | 30 | $12,454 | $415 |
| Omega-3 Acid Ethyl Esters | 50 | $5,390 | $108 |
| Brilinta | 14 | $5,016 | $358 |
| Metoprolol | 223 | $3,681 | $17 |
| Atorvastatin | 369 | $3,475 | $9 |
| Isosorbide Mononitrate Er | 305 | $3,425 | $11 |
| Hydralazine | 209 | $3,395 | $16 |
| Nexium | 13 | $3,304 | $254 |
| Fenofibrate | 105 | $3,097 | $29 |
| Plavix | 13 | $2,921 | $225 |
| Nifedipine Er | 122 | $2,886 | $24 |
| Clopidogrel | 351 | $2,680 | $8 |
| Isosorbide Dinitrate | 50 | $2,310 | $46 |
| Valsartan | 69 | $2,191 | $32 |
| Carvedilol | 340 | $1,916 | $6 |
| Potassium Chloride | 134 | $1,911 | $14 |
| Losartan | 323 | $1,792 | $6 |
| Nitrostat | 65 | $1,764 | $27 |
| Warfarin | 177 | $1,354 | $8 |
| Digoxin | 34 | $1,198 | $35 |
| Afeditab Cr | 50 | $1,119 | $22 |
| Amlodipine Besylate | 331 | $1,110 | $3 |
| Metoprolol | 206 | $919 | $4 |
| Amiodarone | 91 | $872 | $10 |
| Furosemide | 235 | $804 | $3 |
| Spironolactone | 133 | $733 | $6 |
| Nifedical Xl | 28 | $689 | $25 |
| Diltiazem 24hr Er | 32 | $631 | $20 |
| Enalapril Maleate | 22 | $598 | $27 |
| Simvastatin | 107 | $518 | $5 |
| Diltiazem 24hr Cd | 33 | $506 | $15 |
| Digitek | 11 | $465 | $42 |
| Clonidine | 89 | $397 | $4 |
| Atenolol | 142 | $363 | $3 |
| Nitroglycerin | 12 | $324 | $27 |
| Lisinopril | 71 | $318 | $4 |
| Allopurinol | 12 | $234 | $20 |
| Cilostazol | 11 | $142 | $13 |
| Minoxidil | 16 | $121 | $8 |
| Benazepril | 17 | $110 | $6 |
| Losartan-Hydrochlorothiazide | 19 | $90 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $83 | $7 |
| Amoxicillin | 28 | $59 | $2 |
| Ranitidine | 16 | $51 | $3 |
| Hydrochlorothiazide | 20 | $48 | $2 |
2015: 70 drugs
| Xarelto | 131 | $47,560 | $363 |
| Crestor | 73 | $18,929 | $259 |
| Eliquis | 33 | $12,546 | $380 |
| Ranexa | 41 | $11,761 | $287 |
| Diovan | 39 | $11,305 | $290 |
| Nexium | 35 | $8,580 | $245 |
| Pradaxa | 25 | $8,213 | $329 |
| Omega-3 Acid Ethyl Esters | 48 | $5,863 | $122 |
| Fenofibrate | 111 | $5,611 | $51 |
| Plavix | 19 | $5,199 | $274 |
| Isosorbide Mononitrate Er | 350 | $5,016 | $14 |
| Januvia | 14 | $4,742 | $339 |
| Effient | 15 | $4,583 | $306 |
| Valsartan | 59 | $3,457 | $59 |
| Metoprolol | 222 | $3,353 | $15 |
| Brilinta | 11 | $3,117 | $283 |
| Atorvastatin | 281 | $3,096 | $11 |
| Hydralazine | 188 | $2,929 | $16 |
| Benicar | 14 | $2,682 | $192 |
| Nifedipine Er | 96 | $2,589 | $27 |
| Clopidogrel | 277 | $2,451 | $9 |
| Potassium Chloride | 152 | $2,354 | $15 |
| Losartan | 383 | $2,248 | $6 |
| Nitrostat | 103 | $2,203 | $21 |
| Lovaza | 11 | $2,051 | $186 |
| Warfarin | 197 | $1,732 | $9 |
| Midodrine | 15 | $1,481 | $99 |
| Carvedilol | 237 | $1,295 | $5 |
| Amlodipine Besylate | 322 | $1,275 | $4 |
| Coumadin | 14 | $1,191 | $85 |
| Telmisartan-Hydrochlorothiazid | 11 | $1,172 | $107 |
| Digoxin | 32 | $1,033 | $32 |
| Amiodarone | 138 | $975 | $7 |
| Isosorbide Dinitrate | 20 | $960 | $48 |
| Spironolactone | 179 | $929 | $5 |
| Diltiazem Er | 21 | $874 | $42 |
| Furosemide | 238 | $797 | $3 |
| Metoprolol | 179 | $793 | $4 |
| Metolazone | 19 | $766 | $40 |
| Afeditab Cr | 20 | $716 | $36 |
| Enalapril Maleate | 20 | $683 | $34 |
| Labetalol | 12 | $681 | $57 |
| Benazepril-Hydrochlorothiazide | 13 | $620 | $48 |
| Diltiazem 24hr Cd | 28 | $606 | $22 |
| Simvastatin | 92 | $498 | $5 |
| Pravastatin | 20 | $410 | $20 |
| Atenolol | 118 | $389 | $3 |
| Minoxidil | 39 | $374 | $10 |
| Digox | 13 | $371 | $29 |
| Nifedical Xl | 17 | $343 | $20 |
| Clonidine | 38 | $318 | $8 |
| Levothyroxine | 17 | $314 | $18 |
| Lisinopril | 57 | $299 | $5 |
| Propranolol | 14 | $260 | $19 |
| Allopurinol | 15 | $242 | $16 |
| Benazepril | 33 | $218 | $7 |
| Diltiazem 24hr Er | 18 | $216 | $12 |
| Diltiazem | 12 | $200 | $17 |
| Levofloxacin | 28 | $178 | $6 |
| Omeprazole | 14 | $138 | $10 |
| Glyburide | 13 | $117 | $9 |
| Alendronate | 13 | $82 | $6 |
| Paroxetine | 11 | $74 | $7 |
| Metformin | 23 | $65 | $3 |
| Losartan-Hydrochlorothiazide | 14 | $63 | $4 |
| Amoxicillin | 21 | $58 | $3 |
| Glimepiride | 11 | $57 | $5 |
| Glipizide | 17 | $44 | $3 |
| Lisinopril-Hydrochlorothiazide | 11 | $36 | $3 |
| Ranitidine | 13 | $32 | $2 |
2014: 73 drugs
| Xarelto | 63 | $22,277 | $354 |
| Diovan | 81 | $15,876 | $196 |
| Nexium | 53 | $12,910 | $244 |
| Januvia | 29 | $10,047 | $346 |
| Crestor | 45 | $9,888 | $220 |
| Pradaxa | 20 | $5,924 | $296 |
| Metoprolol | 255 | $5,505 | $22 |
| Lovaza | 28 | $5,427 | $194 |
| Ranexa | 27 | $5,418 | $201 |
| Restasis | 11 | $4,285 | $390 |
| Lantus | 12 | $4,260 | $355 |
| Lidoderm | 16 | $4,256 | $266 |
| Avodart | 20 | $3,515 | $176 |
| Effient | 13 | $3,513 | $270 |
| Isosorbide Mononitrate Er | 247 | $3,510 | $14 |
| Hydralazine | 158 | $3,411 | $22 |
| Atorvastatin | 231 | $2,756 | $12 |
| Benicar | 18 | $2,724 | $151 |
| Warfarin | 267 | $2,676 | $10 |
| Clopidogrel | 261 | $2,555 | $10 |
| Namenda | 13 | $2,448 | $188 |
| Losartan | 292 | $2,196 | $8 |
| Potassium Chloride | 123 | $2,040 | $17 |
| Labetalol | 23 | $1,892 | $82 |
| Amlodipine Besylate | 375 | $1,824 | $5 |
| Nifedipine Er | 55 | $1,688 | $31 |
| Fenofibrate | 24 | $1,653 | $69 |
| Carvedilol | 187 | $1,573 | $8 |
| Isosorbide Dinitrate | 30 | $1,302 | $43 |
| Amiodarone | 100 | $1,075 | $11 |
| Furosemide | 258 | $945 | $4 |
| Spironolactone | 180 | $884 | $5 |
| Nitrostat | 59 | $827 | $14 |
| Diltiazem 24hr Cd | 43 | $798 | $19 |
| Metoprolol | 137 | $764 | $6 |
| Valsartan-Hydrochlorothiazide | 11 | $752 | $68 |
| Simvastatin | 132 | $739 | $6 |
| Levofloxacin | 50 | $667 | $13 |
| Digoxin | 15 | $619 | $41 |
| Voltaren | 13 | $586 | $45 |
| Diltiazem Er | 19 | $561 | $30 |
| Afeditab Cr | 23 | $546 | $24 |
| Sure Comfort | 15 | $525 | $35 |
| Metolazone | 18 | $487 | $27 |
| Digox | 12 | $487 | $41 |
| Benazepril | 69 | $428 | $6 |
| Atenolol | 103 | $399 | $4 |
| Enalapril Maleate | 26 | $298 | $11 |
| Nitrofurantoin | 12 | $267 | $22 |
| Triamcinolone Acetonide | 17 | $253 | $15 |
| Clonidine | 31 | $244 | $8 |
| Doxazosin Mesylate | 11 | $211 | $19 |
| Zolpidem | 18 | $202 | $11 |
| Levothyroxine | 19 | $201 | $11 |
| Losartan-Hydrochlorothiazide | 15 | $191 | $13 |
| Donepezil | 17 | $181 | $11 |
| Alendronate | 23 | $169 | $7 |
| Metformin | 36 | $158 | $4 |
| Omeprazole | 22 | $149 | $7 |
| Diclofenac | 13 | $147 | $11 |
| Gabapentin | 15 | $128 | $9 |
| Ranitidine | 21 | $113 | $5 |
| Lisinopril | 23 | $99 | $4 |
| Amoxicillin | 24 | $98 | $4 |
| Hydrochlorothiazide | 20 | $88 | $4 |
| Paroxetine | 11 | $87 | $8 |
| Glyburide | 12 | $85 | $7 |
| Glimepiride | 15 | $82 | $5 |
| Allopurinol | 12 | $76 | $6 |
| Propranolol | 18 | $76 | $4 |
| Lorazepam | 13 | $61 | $5 |
| Alprazolam | 11 | $46 | $4 |
| Glipizide | 14 | $43 | $3 |
2013: 38 drugs
| Multaq | 20 | $7,839 | $392 |
| Nexium | 28 | $7,395 | $264 |
| Diovan | 12 | $2,308 | $192 |
| Crestor | 12 | $2,051 | $171 |
| Metoprolol | 77 | $1,817 | $24 |
| Warfarin | 159 | $1,680 | $11 |
| Micardis Hct | 12 | $1,653 | $138 |
| Avodart | 12 | $1,577 | $131 |
| Clopidogrel | 79 | $1,570 | $20 |
| Nifedipine Er | 36 | $1,418 | $39 |
| Atorvastatin | 54 | $1,197 | $22 |
| Metoprolol | 144 | $1,117 | $8 |
| Carvedilol | 105 | $1,046 | $10 |
| Potassium Chloride | 65 | $930 | $14 |
| Hydralazine | 40 | $922 | $23 |
| Isosorbide Mononitrate Er | 63 | $911 | $14 |
| Amlodipine Besylate | 124 | $847 | $7 |
| Amiodarone | 49 | $770 | $16 |
| Simvastatin | 95 | $681 | $7 |
| Furosemide | 121 | $432 | $4 |
| Diltiazem 24hr Er | 15 | $371 | $25 |
| Losartan | 30 | $358 | $12 |
| Nitrostat | 24 | $314 | $13 |
| Spironolactone | 41 | $286 | $7 |
| Atenolol | 42 | $263 | $6 |
| Benazepril | 38 | $249 | $7 |
| Levofloxacin | 28 | $249 | $9 |
| Omeprazole | 17 | $195 | $11 |
| Digoxin | 21 | $188 | $9 |
| Digox | 16 | $128 | $8 |
| Lorazepam | 26 | $123 | $5 |
| Clonidine | 16 | $121 | $8 |
| Paroxetine | 12 | $117 | $10 |
| Alendronate | 14 | $102 | $7 |
| Hydrochlorothiazide | 19 | $85 | $4 |
| Metformin | 16 | $72 | $5 |
| Allopurinol | 11 | $70 | $6 |
| Hydrocodone-Acetaminophen | 11 | $59 | $5 |
Money from drug and device companies
$157 in 2024
| 2024 | 1 | 1 | None | $157 |
| 2023 | 1 | 1 | None | $125 |
| 2022 | 1 | 5 | None | $293 |
| 2021 | 3 | 11 | None | $500 |
| 2020 | 4 | 20 | None | $2,261 |
| 2019 | 13 | 65 | $19,300 | $22,934 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Flx | $157 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2024-12-12 | Watchman Flx | $157 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $125
| Boehringer Ingelheim Pharmaceuticals | Ofev | $125 | 1 payment
|
2022: $293
| Boston Scientific | Emblem Mri S-Icd | $293 | 5 payments
|
2021: $500
| Boston Scientific | Emblem | $316 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $177 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $7 | 1 payment
|
2020: $2,261
| Medtronic Vascular | Closurefast | $1,201 | 9 payments
|
| Boston Scientific | Resonate | $786 | 6 payments
|
| Galderma Laboratories L.P. | None | $144 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $131 | 2 payments
|
2019: $22,934
| Janssen Pharmaceuticals | Xarelto | $15,693 | 23 payments
|
| Boston Scientific | Watchman | $5,670 | 12 payments
|
| Novartis Pharmaceuticals | Entresto | $695 | 6 payments
|
| Galderma Laboratories L.P. | None | $377 | 9 payments
|
| Amgen | Aimovig | $168 | 3 payments
|
| Medtronic Vascular | Corevalve Evolut | $100 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $58 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $36 | 2 payments
|
| Radius Health | Tymlos | $35 | 1 payment
|
| Gilead Sciences | None | $33 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $24 | 1 payment
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| Pfizer | Chantix | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 19.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1548488877
- Licence
- CA A80802California A80802: Current · expires 2028-09-30
- Trained
- Medical College of Wisconsin, 1996 · 30 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207RC0001X (207RC0001X)
- Mailing address
- 8729 Valley Blvd, Unit A, Rosemead, CA, 91770
- NPI first listed
- 2007-04-23
- NPI last updated
- 2013-10-17
This is when the NPI record was last certified, not a medical board exam.